Quantitative Liver Function Tests Using Cholates

Summary

As the treatments for liver disease and the availability of liver transplantation have progressed, the number of patients with end stage liver disease continues to increase. This has increased the need to risk-stratify patients with cirrhosis to better direct their treatments and provide an accurate prognosis for their outcomes. The traditional assessment of the liver patient has been limited to imaging, static measures of "liver function tests" and liver biopsy. This protocol is designed to increase the spectrum of tests in the evaluation of the patient with end stage liver disease.

Timeline

Start

2011-06-23

Primary completion

2020-05-19

Completion

2025-05-20

Outcome

Outcome not reported

Stopped: “PI left institution”

Drugs

Indications